The primary goal of the Cash Flow Kingdom Income Portfolio is to produce an overall yield in the 7% - 10% range. We accomplish this by combining several different income streams to form an attractive, steady portfolio payout. The portfolio's price can fluctuate, but the income stream remains consistent. Start your free two-week trial today!Golub Capital BDC (NASDAQ: GBDC ) is a Business Development Company with a solid track record, high asset quality, and good management. The company yields more than 11% a ...

I am currently a finance student at York University, where I’m building a strong foundation in financial markets and investment strategies. As a dividend investor, I’ve chosen to invest in solid Canadian banks like BMO and TD for their reliable returns and growth potential. Although I’m new to investing, my passion for it drives me to continuously learn and improve. Writing for Seeking Alpha allows me to share my journey, insights, and analyses with a broader audience. My motivation is to engage with the in ...

A financial researcher and avid investor with a keen eye for innovation and disruption, as well as growth buy-outs and value stocks. Keeping an eye on the pace of high tech and early growth companies, I write about current events and the biggest news surrounding the industry, and strive to provide readers with ample research and investment opportunities.Analyst’s Disclosure: I/we have a beneficial long position in the shares of GSBD either through stock ownership, options, or other derivatives. I wrote this ...

Since December 2023, I have been long Gladstone Investment (NASDAQ: GAIN ), making a case that the monthly yield here is safe and that investors could also expect stable performance going forward, even though the BDC market, currently, seems to be rather challenging.Roberts Berzins has over a decade of experience in the financial management helping top-tier corporates shape their financial strategies and execute large-scale financings. He has also made significant efforts to institutionalize REIT framework ...

CHICAGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (NASDAQ: MRCC) today announced its financial results for the third quarter ended September 30, 2024. Except where the context suggests otherwise, the terms “Company,” “we,” “us,” and “our” refer to Monroe Capital Corporation (together with its subsidiaries). Third Quarter 2024 Financial Highlights Net Investment Income ("NII") of $6.5 million, or $0.30 per shareAdjusted Net Investment Income (a non-GAAP measure described below) of $6.6 mi ...

LOS ANGELES, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.64 per share and net income of $0.41 per share for the quarter ended September 30, 2024. Reported net asset value per share was $20.20 as of September 30, 2024. Dividend Declarations   The Company’s Board of Directors (the “Board”) declared a fourth quarter 2024 regular cash dividend of $0.42 per share to stockholders of record as of December 31, 2 ...

Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company ("BDC") sector from both the bottom-up - highlighting individual news and events - as well as the top-down - providing an overview of theCheck out Systematic Income and explore our Income Portfolios, engineered with both yield and risk management considerations. Use our powerful Interactive Investor Tools to navigate the BDC, CEF, OEF, preferred and baby bond markets.Read our ...

NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (“LIEN” or the “Company”) (NASDAQ: LIEN), formerly Silver Spike Investment Corp., a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights and Subsequent Events Total investment income of $3.2 millionNet investment income of $0.0 million, or $0.00 per shareInvestment portfolio of $55.8 ...

BDC-4182 demonstrated compelling anti-tumor activity and an acceptable safety profile in preclinical studies BDC-4182 outperformed cytotoxic claudin 18.2 ADCs in syngeneic model Learnings from BDC-1001 data suggest Boltbody™ ISACs with enhanced immune activation could offer greater efficacy, warranting further testing REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of c ...

I am a writer with diverse interests from creative writing to physics to tennis and music. Another interest is markets/investing. I live on the Israeli Golan Heights.I believe in research as a critical component of any investing decision. I find company dynamics and adjustments to market conditions a very interesting interplay. I enjoy writing about companies and managing my portfolio - and learning about the markets.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of t ...